Pharmacokinetics of 5-Fluorouracil following Different Routes of Intrahepatic Administration in the Canine Model

Mukund S. Didolkar, David G. Covell, Alonzo P. Walker, Andre J. Jackson, Sanyasi R. Kalidindi

Research output: Contribution to journalArticlepeer-review

7 Scopus citations


In an effort to achieve high concentrations of 5-fluorouracil (5-FUra) in the hepatic circulation while minimizing systemic exposure, several routes of intrahepatic administration were compared in the canine model. To ascertain these data, 5-FUra (30 mg/kg) was given as a bolus into either a systemic vein (femoral vein), hepatic artery, hepatic artery distal to its ligation after hepatic deartehalization, or through the portal vein. Three dogs were studied for each route with concomitant blood samples taken from the inferior vena cava and hepatic vein at 1, 2, 3, 5, 10,15, 30, and 60 min after injection. 5-FUra levels were determined in plasma by high-pressure liquid chromatography. Blood flow in the portal vein and hepatic artery was measured by an electromagnetic flowmeter. The data were best described by a multicompartmental model including the measured flows. Hepatic components of the model were separate arterial and portal compartments, with elimination from each described by linear kinetics. Analysis of the results indicated that the highest hepatic levels with the least systemic exposure, as indicated by drug levels in hepatic and peripheral vein, were realized following hepatic artery administration distal to its ligation after hepatic dearterialization.

Original languageEnglish (US)
Pages (from-to)5105-5109
Number of pages5
JournalCancer Research
Issue number11
StatePublished - Nov 1 1984
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Pharmacokinetics of 5-Fluorouracil following Different Routes of Intrahepatic Administration in the Canine Model'. Together they form a unique fingerprint.

Cite this